Overview
For professionals who have moved beyond the basics, advanced GCP Trainings offer the depth required to navigate the complex global regulatory landscape. These trainings are not just about understanding the rules; they are about mastering the science of quality and risk management in clinical research. As a clinical research professional, you are responsible for ensuring that trials are conducted ethically, data is reliable, and participants are protected. This requires a nuanced understanding of multiple regulatory frameworks including ICH, Health Canada, and FDA requirements. Our advanced courses dive into the specifics of ICH E6(R3), Health Canada Division 5, FDA regulations, HIPAA compliance, and GCP auditing.
The Need for Advanced Clinical Compliance
The clinical research industry is moving toward more complex trial designs, including decentralized and hybrid models, and the integration of digital technologies. This shift requires a workforce that is not only trained but educated in the principles of risk-based and proportionate approaches. Advanced GCP Trainings help professionals identify potential compliance gaps and implement robust preventive measures. Our courses are designed for those who are ready to lead compliance efforts and drive continuous improvement within their organizations. By mastering these advanced topics, you become an invaluable asset to your team.
Detailed Course Breakdown
Course 1: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline, the globally recognized standard for the ethical and scientific quality of clinical trial design, conduct, and reporting.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
Pricing: $149.00 with group discounts available.
FAQ:
- How does ICH E6(R3) support global clinical compliance? It provides a harmonized framework for GCP that is recognized globally, enabling consistent trial conduct across jurisdictions.
- What is the significance of Annex 1 in ICH E6(R3)? Annex 1 provides specific guidance on interventional clinical trials, building on the fundamental principles in the main body of the guideline.
- How does ICH E6(R3) address risk-based monitoring? The guideline emphasizes proportionate and risk-based approaches to trial management, allowing resources to be focused on areas of highest risk.
- What is the role of data governance in ICH E6(R3)? Data governance frameworks ensure the integrity, accuracy, and reliability of clinical trial data.
- How does ICH E6(R3) integrate digital technologies? The guideline provides a framework for the integration of digital health technologies, electronic data capture, and remote monitoring in clinical trials.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 2: Health Canada Good Clinical Practice Training
This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) GCP guideline.
Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026. It covers Health Canada regulatory requirements, sponsor and Qualified Investigator responsibilities, clinical trial application processes, informed consent, safety reporting, data governance, quality management, and inspection readiness.
Description of Modules: The curriculum covers:
- Health Canada regulatory requirements for clinical trials (Part C, Division 5)
- ICH E6(R3) GCP principles and Annex 1
- Sponsor, Qualified Investigator, and REB responsibilities
- Clinical trial application (CTA) and amendment processes
- Informed consent requirements and participant protection
- Safety reporting obligations (AEs, SAEs, SUSARs)
- Data governance and record-keeping requirements
- Quality management and risk-based monitoring
- Investigational product management and GMP compliance
Target Audience:
- Sponsors (commercial and non-commercial/academic)
- Qualified Investigators and Principal Investigators
- Research Ethics Board (REB) members and administrators
- Clinical Research Coordinators and study site personnel
- Contract Research Organizations (CROs) and Service Providers
Pricing: Competitive pricing with group discounts available.
FAQ:
- What are the key requirements for a Qualified Investigator under Health Canada? The Qualified Investigator must be qualified by education, training, and experience, and must supervise the conduct of the clinical trial.
- What is the Clinical Trial Application (CTA) process in Canada? Sponsors must submit a CTA to Health Canada for authorization before initiating a clinical trial.
- What are the safety reporting timelines under Health Canada? Health Canada requires expedited reporting of serious adverse events and suspected unexpected serious adverse reactions within specified timelines.
- What is ALCOA+ and why is it important? ALCOA+ stands for Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available – principles for ensuring data integrity.
- What is the role of GMP in clinical trials? Investigational products must be manufactured in compliance with GMP requirements to ensure quality and safety.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 3: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- What is the HIPAA Privacy Rule? It establishes national standards to protect individuals’ medical records and other personal health information.
- What is the HIPAA Security Rule? It establishes national standards to protect electronic protected health information that is created, received, used, or maintained by a covered entity.
- What is the HIPAA Breach Notification Rule? It requires covered entities to provide notification following a breach of unsecured protected health information.
- What is the role of NIST in HIPAA compliance? NIST provides frameworks and guidelines for security and privacy controls that support HIPAA compliance.
- What is the importance of incident management in HIPAA? Incident management ensures timely detection, response, and reporting of security incidents involving PHI.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 4: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations (21 CFR Parts 50, 56, 312, 314.50, and 314.80) with auditing practices based on ISO 19011:2026.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR
- Auditing Practices based on ISO 19011:2026
- Remote auditing methods including virtual audits
- Second-party auditing including supplier qualification
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
Pricing: $499.00 with group discounts available.
FAQ:
- What is the role of ISO 19011:2026 in GCP auditing? It provides the methodological framework for planning, conducting, reporting, and following up on audits.
- What are the key elements of audit programme management? Objectives, risks, resources, procedures, implementation, monitoring, review, and improvement.
- What is remote auditing and when is it used? Remote auditing uses virtual methods and technology to conduct audits, particularly useful for global trials.
- What is second-party auditing? Second-party auditing involves auditing suppliers, vendors, and service providers.
- What is the importance of auditor competence? Auditors must demonstrate personal behaviour, knowledge, skills, and maintain competence through ongoing evaluation.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape. The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management, with specific focus on the regulatory requirements of the FDA, EMA, and PMDA.
Scope: The program is structured to provide both foundational regulatory knowledge and advanced strategic capabilities across all major application types.
Description of Modules: The curriculum covers:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
- CMC Specialists and Manufacturing Personnel
- Project Management Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
- What is the eCTD format and why is it important? eCTD (Electronic Common Technical Document) is the standard format for regulatory submissions.
- What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
- What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.
- What are the key elements of a Biologics License Application (BLA)? A BLA includes manufacturing information, nonclinical studies, clinical data, and labeling for biological products.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
